Introduction
Infection of mammalian cells with herpes simplex virus type 1 or type 2 (HSV-1 or HSV-2) results in the induction of a novel enzyme activity, alkaline nuclease (Hoffmann & Cheng, 1978; Keir & Gold, 1963) . Alkaline nuclease purified from HSV-infected cells exhibits exo-and endonuclease activities and differs from host cell nucleases in its high pH optimum (Francke etal., 1978; Hoffmann, 1981 ; Hoffmann & Cheng, 1978 Morrison & Keir, 1968; Strobel-Fidler & Francke, 1980) . Two lines of evidence indicate that alkaline nuclease is virus-encoded: the isolation of a temperaturesensitive (ts) mutant affecting the activity of the enzyme (Francke et al., 1978) and the demonstration that microinjection of HSV DNA fragments into Xenopus laevis oocytes results in the production of alkaline nuclease activity (Preston & Cordingley, 1982) . HSV alkaline nuclease is a relatively abundant phosphoprotein in infected cells and has an apparent Mr of 85000 (85K) (Banks et al., , 1985 . The alkaline nuclease localizes to sites in the nucleus of infected cells which are distinct from the putative replication compartments in which HSV replication proteins ICP8 and DNA polymerase are found (de Bruyn Kops & Knipe, 1988; Knipe, 1989; Puvion-Dutilleul & Pichard, 1986; Randall & Dinwoodie, 1986) .
The nuclease gene maps between 0-168 and 0-175 map units on the genomes of HSV-1 and HSV-2 (Banks et al., 1985; Costa et al., 1983; Preston & Cordingley, 1982; Wathen & Hay, 1984) . The mRNA encoding alkaline nuclease has been mapped to a 2.3 kb mRNA which is a member of a family of unspliced 3'-coterminal mRNAs (Costa et al., 1983) . The DNA sequence of this region reveals an open reading frame (ORF) encoding 626 amino acids, designated UL12 within the 2.3 kb mRNA (Costa et al., 1983; Draper et al., 1986; McGeoch et al., 1986 McGeoch et al., , 1988b . The amino acid sequences of the HSV-1 and -2 nuclease genes are clearly related to sequences found in other herpesviruses, such as the Epstein-Barr virus BGLF5 gene (Baer et al., 1984) and varicella-zoster virus gene 48 (Davison & Scott, 1986 ).
The precise role of the alkaline nuclease in the viral life cycle is unknown. Studies with an HSV-2 ts mutant have been complicated by the fact that this mutant is somewhat leaky (exhibits residual nuclease activity at the non-permissive temperature) and may contain more than one mutation; investigators have reached different conclusions regarding whether the alkaline nuclease gene is essential for viral DNA synthesis (Franke & Garrett, 1982; Moss, 1986; Moss et al., 1979) . To circumvent problems with potential by leaky ts mutants, we have used an alternative approach for the isolation of mutations in targeted genes. This strategy consists of two components: (i) the isolation of host cell lines containing HSV DNA which are able to support the growth of potentially lethal null mutants and (ii) the construction of null mutants using an insertional mutagen consisting of the lacZ gene of Escherichia coil under the control of the regulatory elements of the large subunit of ribonucleotide reductase (ICP6). We have used this strategy to examine the roles of several HSV genes in DNA replication, including ribonucleotide reductase (Goldstein & Weller, 1988a) , UL8 (Carmichael & Weller, 1989) , UL9 and UL52 (Goldstein & Weller, 1988b) . In this report we describe the isolation of a deletion/insertion mutant in the alkaline nuclease gene. Our results indicate that the HSV-1 alkaline nuclease activity is not essential for viral DNA synthesis but may play a role in the processing or packaging of viral DNA into infectious virions.
Methods
Cells and viruses. African green monkey kidney cells (Veto; ATCC) were grown and maintained as described previously (Weller et al., 1983) . $22 cells containing approximately five copies of the right-hand portion of the EcoRI D fragment (coordinates 0.086 to 0.194; sequence coordinates 12 593 to 29 338) of the HSV-1 genome (Carmichael et al., 1988) were grown in the presence of 250 Izg/ml G418 (Geneticin; Gibco Laboratories). The KOS strain of HSV-1 was used as the wild-type virus. Viruses were propagated and assayed as described previously (Schaffer et al., 1978) .
Plasmids and bacteria. The plasmid pSGI0, containing the EcoRI D fragment of HSV-1 strain KOS (See Table 3 for coordinates), was described previously (Goldin et al., 1981) ; the construction of pSG10-BD2, containing a 3.1 kb BamHI-HindIII fragment (see Fig. 1 and Table 3), was also described previously (WeUer et al., 1987) . [DNA sequence information indicates that a BamHI site is present at position 24890 in HSV-1 strain KOS but not in strain 17 (L. Shao & S. K. Weller, unpublished data)]. Plasmid pBS-BD2 was constructed by inserting the BamHI-HindlII fragment from pSG10-BD2 into the vector Bluescribe (Stratagene). Plasmid pTZDN7, containing a 2.3 kb BamHI-BstEII fragment (see Fig. 1 and Table 3) in the vector pTZ19U (U.S. Biochemicals) was generously provided by Dr D. Parris, Ohio State University, Columbus, Ohio, U.S.A. Plasmids pSG 10-P5 and P6 containing PstI fragments (see Table 3 ) were described previously (Carmichael et al., 1988) . The construction of pD6p which contains the lacZ gene under the control of the ICP6 regulatory region was described previously (Goldstein & Weller, 1988b) .
pAN-1 containing a 917 bp deletion and a lacZ insertion in the alkaline nuclease gene was constructed as follows. The BamHI site in the polylinker of pBS-BD2 was removed by digestion with BamHI and EcoRI, the ends were filled using the large fragment of DNA polymerase I, EcoRI linkers were ligated and the plasmid was circularized by ligation at low DNA concentration. The resulting plasmid, pBS-BD2AB, was digested with HpaI and NcoI, the ends were filled in with the large fragment of DNA polymerase I and BamHl linkers were ligated to the blunt ends. The plasmid was circularized by ligation at low DNA concentration to generate pBS-BD2ABHN, which (Sp) . Two members of the Y-coterminal family of mRNAs which map to this region are shown: the 0.9 kb mRNA encoding the ULI10RF [24805 (C) to 25093] and the 2-3 kb mRNA encoding the nuclease lULl20RF, 25011 (C) to 26889] (Costa et al., 1983; McGeoch et al., 1988b) . ORFs are shown as boxes. (b) The HSV-1 DNA inserts in pBS-BD2 (24890 to 27986) and pTZDN7 (24890 to 27265) are indicated. (c) Displays a diagram of the mutation in pAN-l which has a 917 bp deletion and a lacZ gene insertion.
contains a 917 bp deletion and a unique BamHI site at the position of the deletion, pAN-1 was constructed by inserting the 4.2 kb BamHI fragment from pD6p, containing the coding region of the lacZ flgalactosidase (fl-gal) gene of E. coli under control of the ICP6 regulatory sequences, into the BamHI site of pBS-BD2ABHN; the insertional mutagen was described previously (Goldstein & Weller, 1988b) . Recombinant plasmids were propagated in E. coli JM83 or DH5 by standard procedures (Maniatis et al., 1982) .
Isolation and analysis of viral and cellular DNAs. Infectious virus DNA was isolated from purified virions as described (Goldstein & Weller, 1988b) . Virus pellets were lysed by the addition of SDS and proteinase K to final concentrations of 0.1% and 100 ~tg/ml, respectively. Tubes were inverted gently and incubated at 37 °C for 3 to 5 h. Samples were dialysed and concentrated, using an autoclaved Schleicher and Schuell Model UH020/2A microdialysis apparatus at room temperature, against four changes (60 min each) of 20% (w/v) polyethylene glycol (PEG) 8000 (Sigma) in sterile Tris-EDTA (TE) buffer (Longmire et al., 1987) . Sample volumes decreased approximately 10-fold during PEG dialysis. Desalting was accomplished by dialysis against two or three changes (30 min each) of sterile TE buffer at room temperature. DNA samples were carefully transferred (to avoid shearing) to sterile tubes and stored at -70 °C.
DNA to be analysed by restriction enzyme digestion was isolated as described above except that samples were extracted three to five times with phenol :chloroform :isoamyl alcohol (25:24: l) and precipitated with ethanol. Plasmid or viral DNA was digested with restriction endonuclease(s) as directed by the manufacturer, separated by agarose gel electrophoresis in Tris-borate-EDTA buffer and transferred to a GeneScreen-Plus nylon membrane (New England Nuclear) as recommended by the supplier. Recombinant DNAs used for probes for hybridization were labelled as described by Feinberg & Vogelstein (1983) .
Marker rescue and marker transfer. Marker rescue and marker transfer experiments were performed as described by Goldstein & Weller (1988 b) . For marker transfer of the deletion/insertion mutation into HSV-I strain KOS DNA, 200 to 1000 infectious units (approximately 1 lag) of wild-type viral DNA were cotransfected with a 10-fold molar excess of the recombinant plasmid. The 7.1 kb insert containing the alkaline nuclease gene with the ICP6 : : lacZ insertion was excised from pAN-1 by digestion with NruI. This fragment was used with infectious HSV-1 strain KOS DNA to cotransfect $22 cells. When the c.p.e, was maximal, the virus was harvested and titrated on $22 cells. Plaques were stained simultaneously with neutral red and the chromogenic substrate 5-bromo-4-chloro-3-indoyl-fl-D-galactoside (Xgal) as described (Goldstein & Weller, 1988a) . Blue plaques were purified three times on $22 cells before stocks were made.
Synthesis of viral DNA in infected cells. Viral DNA synthesis was analysed as described previously (Aron et al., 1975) except that proteinase K was used instead of pronase. The non-permissive condition was growth in Vero cells and the permissive condition was growth in 822 cells, both at 37 °C.
Alkaline nuclease assays. Crude extracts from HSV-infected cells were prepared essentially as described previously (Francke & Garren, 1982) . Vero cells (5 x 106 in a 60 mm dish) were infected with HSV-I strain KOS or virus AN-1 at an m.o.i, of 10. At 12 h post-infection (p.i.), the cells were washed in NTM buffer (150 mM-NaC1, 50 mMTris-HC1 pH 7.5, 2 mM-2-mercaptoethanol) and scraped into 2 ml NTM buffer. Cells from each plate were pelleted at 500g for 10 rain at 4 °C and cell pellets were resuspended in 200 lal of 20 mM-Tris-HC1 pH 7.5 containing 5 mM 2-mercaptoethanol. Cells were disrupted by sonicating twice for 30 s in an ice water-cooled Heat Systems sonifier cell disruptor, and samples were adjusted to final salt concentrations of 4 mM-MgCl2 and 100 mM-KCI. Cell debris was removed by centrifugation for 15 rain at 1500 g. Nuclease assays were performed in 100 lal reaction mixtures containing 50 lal crude extract, 2.4 lag of 3H-labelled E. coli DNA (8.3 x 103 c.p.m./lag), 20 gg unlabelled salmon sperm DNA, 50 mM-Tri~HCI pH 9.0, 2 mM-MgC12 and 10 mM-2-mercaptoethanol. Digestion of labelled DNA in HSV-1 strain KOSinfected extracts was complete in the presence or absence of the unlabelled DNA. Reactions were carried out at 37 °C and 14 lal aliquots were withdrawn at 0, 10 and 30 rain. The release of acid-soluble 3H-labelled nucleotides was measured as described by Morrison & Keir (1968) . Results are presented as 3H c.p.m, rendered acid-soluble from labelled high Mr DNA. Each reaction contained 50 lag of cellular protein, corresponding to approximately 1.25 x 106 cells.
Analysis of viral proteins. Vero or $22 cells were infected with HSV-I strain KOS or mutant virus at an m.o.i, of 10 p.f.u, per cell. Cells were labelled at 5 h p.i. with [3sS]methionine as described previously (Weller et al., 1987) . At 16 h p.i. cells were harvested and the samples subjected to electrophoresis as described previously (Goldstein & Weller, 1988a) .
Immunoblotting of HSV-infected cell extracts. Specific polyclonal antisera raised in rabbits against a fusion protein containing flgalactosidase and a portion of the alkaline nuclease gene were generously provided by Dr M. Challberg (NIH, Bethesda, Md., U.S.A.). Vero cells were infected with HSV-1 strain KOS at an m.o.i, of 5 p.f.u./cell. Cells were harvested at 12 h p.i., resuspended in 1 ml buffer containing 0.05 M-Tris HCI pH 7.5, 0.15 M-NaCI, 0.1% SDS, 1% sodium deoxycholate and 1% Triton X-100 with five protease inhibitors (0.1 mM-TPCK, 0-1 mM-TLCK, 0.5 mM-PMSF, 250 kallikrein units/ml leupeptin and 2% aprotinin) and immediately boiled for 10 min. The extracts were then sonicated, clarified by centrifugation and stored at -20 °C. Aliquots (50 gl) were subjected to electrophoresis on 9% SDS-polyacrylamide gels (see above) at 40 mA.
Proteins from the gels were electrophoretically transferred to nitrocellulose filters as described by Towbin et al. (1979) . The nitrocellulose filters were then incubated with a 1:500 dilution of the specific antibodies described above and the immunoreactive protein was detected by staining with a goat anti-rabbit antibody conjugated to alkaline phosphatase (nitroblue tetrazolium and 5-bromo-4-chloro-3-indolyl phosphate were purchased from Promega Biotec). . However, in subsequent experiments using higher non-permissive temperatures, it was discovered that these revertants were actually compromised for growth and DNA synthesis at 38.5 °C (Francke & Garrett, 1982) , suggesting that whereas alkaline nuclease was not absolutely essential for viral DNA synthesis it appeared to be required for optimal DNA synthesis. Moss (1986) subsequently reported that mutant 4-8 was even more compromised in viral DNA synthesis and DNase activity if grown at 39.2 °C. Marker rescue of the ts nuclease lesion with the 16.7 kb EcoRI D fragment restored wild-type levels of viral nuclease activity, virus DNA synthesis and virus growth (Moss, 1986) . These results led to the conclusion that HSV nuclease activity is essential for virus growth and viral DNA synthesis (Moss, 1986) .
Results
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To extend these studies to HSV-1 and to provide further genetic evidence concerning the role of alkaline nuclease in viral DNA replication, we set out to isolate a null mutant in the HSV-1 alkaline nuclease gene which would express no residual activity under non-permissive growth conditions. We previously reported the isolation and characterization of a cell line ($22) 
Isolation of a deletion/lacZ mutant in the alkaline nuclease gene
The plasmid pAN-1 was constructed such that 917 bp from the N-terminal half of the gene (corresponding to residues 70 to 375 of ORF UL12) was replaced by the insertional mutagen ICP6::lacZ (see Fig. 1 ). The ICP6 : : lacZ cassette contains the structural gene encoding fl-gal under the control of the regulatory region of ICP6. Genes under the control of this regulatory region can be induced by the virion stimulatory protein, VP16, and also by the trans-inducing protein, ICP0 (L. Zhu & S. K. Weller, unpublished results) . In this construct, fl-gal can be induced to relatively high levels of expression (Goldstein & Weller, 1988b) . Introduction of the altered alkaline nuclease gene in pAN-1 into the viral genome results in the disruption of the alkaline nuclease gene; a stop codon at the end of the lacZ gene ensures that the remaining portion of the alkaline nuclease is not expressed. Marker transfer experiments with pAN-1 and infectious wild-type DNA in $22 cells were carried out as described in Methods. The use of the lacZ gene as an insertional mutagen facilitated screening for recombinant virus because fl-gal activity is readily detected by the formation of blue colour after staining with X-gal. Recombinant viruses (approximately 0.1 ~o) were identified and two independently isolated recombinant viruses, AN-1 and AN-2, were plaque-purified on $22 cells. AN-1 was used in the current studies but AN-2 exhibited identical phenotypic and genetic characteristics.
Restriction analysis of AN-1
To confirm that AN-1 contains the ICP6:: lacZ cassette at the appropriate position, DNAs from HSV-1 strain KOS, virus AN-1 and plasmids pBS-BD2 and pAN-1 were digested with BgllI and HindlII and subjected to gel electrophoresis and Southern blot hybridization as described in Methods. Duplicate filters were hybridized to either the 32p-labelled BamHI-HindlII fragment from pBS-BD2 (Fig. 2a) or the 32p-labelled lacZ fragment (Fig. 2b) . HSV-1 strain KOS and pBS-BD2 DNA (Fig.  2a, lanes 1 and 2) contain the wild-type 2.7 kb form of the BgllI-HindlII fragment, whereas HSV-1 strain AN-1 and pAN-1 (Fig. 2a, lanes 3 and 4) contain the 6.0 kb version expected if the 917 bp deletion and the 4.2 kb insertion are both present. The band migrating at 3.6 kb in lanes 2 and 4 corresponds to the vector which hybridizes weakly to the probe. The origin of the band migrating a little faster than the 6-0 kb band in virus AN-1 (Fig 2, lane 3) is unclear but may represent crosshybridization of viral sequences to either the vector or viral sequences in the probe. When the duplicate filter was hybridized with a lacZ probe, only the 6.0 kb DNAs from HSV-1 strain KOS (lanes 1 and 8) and virus AN-1 (lanes 3 and 6) were digested with BgBI and HindI]l and subjected to gel electrophoresis in parallel with BglII-IIindIII-digested pBS-BD2 (lanes 2 and 7) and pAN-1 (lanes 4 and 5). DNAs were separated on a 0-8~ agarose gel, blotted onto GeneScreen-Plus, and hybridized to either the 32p-labelled HSV BamHI-IIindIII fragment from pBS-BD2 (a) or to the lacZ fragment from pDP503 (b). fragment of pAN-1 and virus AN-1 was detected. The 3.6 kb band in lanes 5 and 7 corresponds to the vector, as seen above. These results demonstrate that the ICP6::lacZ fragment of pAN-1 was inserted into the expected position of the genome.
Alkaline nuclease activity of AN-1
Extracts of infected Vero cells were assayed for alkaline nuclease activity as described in Methods. Table 1 shows that mock-, and virus AN-l-and AN-2-infected extracts do not exhibit significant amounts of alkaline nuclease activity, whereas HSV-1 strain KOS-infected extracts exhibit considerable activity under these reaction conditions. Furthermore, a recombinant of virus AN-1, AN-ll b, generated during marker rescue analysis (described below), also exhibits wild-type levels of the enzyme. This result indicates that viruses AN-1 and AN-2 are incapable of inducing alkaline nuclease activity above levels obtained from mock-infected cell extracts and is consistent with the assumption that the deletion/ insertion mutation has in fact disrupted the nuclease gene.
Growth properties of AN-1
The mutant AN-1 was tested for its ability to form plaques in untransformed Vero cells and in permissive 2-9 × 106t 6.5 x 107~ AN-I-lb § 1 x 10 a 1-2 x 10 a AN-1-2a § 1-1 x 10 s 8.5 × 107 * Plaquing efficiencies were determined by titrating virus stocks on monolayers of the indicated cell line.
1" Plaques could not be counted easily because they are extremely small and asymmetrical in shape. In six separate experiments, plaquing efficiencies of virus AN-I on Vero cells ranged from 20-to 50-fold lower than that of the same virus on $22 cells.
:~ Plaque sizes of virus AN-1 on $22 cells were slightly smaller than for HSV-1 strain KOS on $22 (see text).
§ AN-I-Ib and AN-1-2a are recombinant viruses obtained in a marker rescue experiment with infectious AN-1 DNA and the plasmids pBS-BD2 and pTZDN7, respectively. Plaque sizes of both recombinants on Vero and $22 were identical to those of HSV-1 strain KOS. Table 2 , the plaquing efficiency of virus AN-1 on Vero cells is considerably lower (20-to 50-fold) than on $22 cells. Plaques of virus AN-1 on Vero cells are very small compared to HSV-1 strain KOS (0.3 to 0-5 mm as compared to 1.6 mm) and have an unusual morphology, being asymmetrical instead of round. Table 2 also shows that virus AN-1 forms plaques efficiently on $22, although the plaque sizes are slightly smaller than those of HSV-1 strain KOS on $22 (1.3 mm compared to 1.6 mm).
$22 cells. As indicated in
To test further the growth properties of virus AN-1 in Vero and $22 cells, we measured the efficiency of virus production by single-step growth analysis (Fig. 3 ). Cells were infected at an m.o.i, of 2 p.f.u./cell and harvested at various times up to 44 h p.i. Yields of virus were titrated in permissive $22 cells. The final AN-1 virus yield in $22 cells was reduced 200-fold compared to HSV-1 strain KOS in the same cells; thus, the mutant is somewhat compromised in its ability to produce virus even in permissive $22 cells. These results suggest that $22 cells cannot fully compensate for the mutation in virus AN-1. Yields of virus AN-1 in Vero cells were reduced approximately 4 x 103-fold compared with wild-type virus in Vero cells, although small amounts of infectious virus are produced. Thus, virus AN-1 is severely compromised in Vero cells but can be propagated on $22 cells. The growth of virus AN-1 was also severely reduced in baby hamster kidney and human foreskin fibroblast cells (data not shown). These results suggest that the alkaline nuclease is required for efficient plaque formation and efficient production of infectious virus.
Genetic analysis
Marker rescue was performed to confirm that the growth defects observed in virus AN-1 were due to the mutation introduced into the nuclease gene. $22 cells were cotransfected with infectious virus AN-1 DNA and the plasmids shown in Table 3 and progeny virus was titrated in Vero and $22 cells. Parental virus AN-1 and recombinants could be distinguished on the basis of § Results are expressed as plating efficiencies, which were determined using the formula [(P.f.u./mlvero)/p.f.u./mls22)] x 103.
II Numbers in italics were considered negative for marker rescue.
plaque size and colour on Vero cells; only white, wildtype-sized plaques were counted in calculating marker rescue frequencies. Plasmids pSG10 and pBS-BD2 both efficiently rescued the lesion in virus AN-l; plasmid pTZDN7 also rescued the lesion but much less efficiently. The reason for the low marker rescue frequency of pTZDN7 is likely to be that the insert in the plasmid extends only 583 bp to the right of the position of the deletion in virus AN-l, thus reducing the region available for homologous recombination. These data are consistent with the conclusion that the growth defect in virus AN-1 is due to the insertion in the alkaline nuclease gene but we cannot rule out the presence of additional lesions because the smallest fragment capable of rescuing the lesion in virus AN-1 [the BamHI-BstEII fragment in pTZDN7 (24890 to 27265 in the HSV-1 strain 17 sequence)] overlaps the UL11 gene by 203 nucleotides on its left end and the UL13 gene by 315 nucleotides on its right end. Thus, it is theoretically possible that the growth defects in virus AN-1 are due to spontaneous mutations within the UL11 or UL13 genes also present within $22 cells. However, we consider this unlikely for two reasons. First, because virus AN-1 plaques are blue in the presence of X-gal, wild-type recombinants can be easily detected by screening for white plaques on Vero cells. The only plasmids which generated white plaques on Vero cells were pSG10, pBS-BD2 and pTZDN7 (data not shown). Twelve white plaques were picked from positive marker rescue plates, and all 12 grew on Vero cells. One white plaque each from the pBS-BD2 and pTZDN7 plates, AN-I-lb and AN-I-2a, respectively, was chosen for further study. ANI-lb and AN-1-2a were able to form large plaques on Vero cells with efficiencies identical to that of wild-type virus (Table 2) . These and f) cells (10 p.f.u./cell) were exposed to 10 ~tCi [3H]thymidine/ml from 6 to 24 h p.i. Cell lysates were subjected to equilibrium centrifugation in neutral CsCI gradients as described previously (Aron et al., 1975) . Cellular DNA corresponds to a peak (C) with a buoyant density of 1.690 g/ml and viral DNA corresponds to a peak (V) with a buoyant density of 1-725 g/ml. Symbols: I-q, c.p.m, x 103; 0, buoyant density plot.
results demonstrate that the loss of the lacZ gene (blue to white plaques) segregated perfectly with the restoration of growth on Vero cells. Second, because two independently isolated mutant viruses, AN-1 and AN-2, exhibited identical phenotypes, it is unlikely that viruses AN-1 and AN-2 both contain additional spontaneous mutations in UL11 or UL13.
Synthesis of viral DNA
The ability of virus AN-1 to synthesize viral DNA was measured by the incorporation of [Me-3H]thymidine. Wild-type-and mutant-infected Vero and $22 cells were labelled and total DNA was harvested as described previously (Aron et al., 1975) . Cellular and viral DNAs were resolved by isopycnic density gradient centrifugation. Fig. 4 
Synthesis of viral proteins
M u t a n t s that synthesize wild-type levels of viral D N A under non-permissive conditions would be expected to induce wild-type levels of late viral proteins. Challberg, u n p u b l i s h e d data). In HSV-I strain KOSinfected $22 and Vero cells (Fig. 6 , lanes 3 and 5, respectively), a major i m m u n o r e a c t i v e b a n d was observed at a position corresponding to an Mr of approximately 85K. In extracts from virus A N -linfected $22 and Vero cells (Fig. 6 , lanes 2 and 4, respectively), the 85K b a n d was absent, however a b a n d corresponding to an Mr of 116K was observed. Since the antiserum was raised against a fl-gal : : alkaline nuclease fusion protein, this large band almost certainly corresponds to fl-gal (l16K), which would be expected to be produced by virus AN-1. Neither the 116K nor the 85K bands was observed in mock-infected $22 or Vero cells (Fig. 6 , lane 1 and data not shown). These results suggest that virus AN-1 does not synthesize a protein corresponding to the wild-type alkaline nuclease protein, confirming the fact that the gene for this protein has been disrupted. It is of interest that no band corresponding to the alkaline nuclease is seen in virus AN-1-infected $22 cells, either in the [35S]methionine-labelled extracts on polyacrylamide gels (Fig. 5, lane 6) or on an immunoblot (Fig.  6, lane 2) . In addition, alkaline nuclease activity has not been detected in $22 cells induced by superinfection with virus AN-1 (data not shown). These results suggest that alkaline nuclease may not be efficiently expressed in $22 cells; the significance of this finding will be discussed further below.
The results described above suggest that although virus AN-1 is severely compromised in plaque formation and production of infectious virus when grown on Vero cells, wild-type levels of viral DNA and proteins are synthesized in these cells. Thus the defect in virus AN-1 appears to act at a later stage than viral DNA synthesis and production of late proteins.
Discussion
We have described the isolation and characterization of a null mutant in the gene encoding the HSV-1 alkaline nuclease. The mutant AN-1 contains a 917 bp deletion of the N-terminal half of the gene (corresponding to residues 70 to 375 of the 626 residue ORF UL12) and an insertion of the ICP6 : : lacZ insertional mutagen. Virus AN-1 was propagated in helper cells ($22) which express the wild-type version of the alkaline nuclease gene and forms tiny, practically indistinguishable plaques on Vero cells. Interestingly, tiny plaques which are difficult to count were also reported for the HSV-2 mutant 4-8 under non-permissive growth conditions (Francke & Garrett, 1982; Moss, 1986) . The plaque size and morphology of alkaline nuclease deficient (nuc-) mutants may indicate an unusual method of viral transmission in the absence of nuclease. In addition, the yield of virus AN-1 when grown on Vero cells was 103-fold less than that of HSV-1 strain KOS. This result suggests that the mutant is severely compromised on Vero cells; however, the presence of a small amount of infectious virus produced suggests that a limited amount of virus production can occur in the absence of viral alkaline nuclease. Electron microscopic studies suggest that a large number of empty capsids accumulate in cells infected with virus AN-1 and that, relative to wild-type virus, few mature extranuclear particles are produced (data not shown). Fig. 4 and 5 indicate that virus AN-1 is capable of inducing wild-type levels of viral DNA and protein synthesis. Taken together, these results suggest that viral alkaline nuclease is not essential for viral DNA replication but is required for the efficient production of infectious virus. Possible roles of the alkaline nuclease in the viral life cycle are discussed below.
A discrepancy exists between the conclusions reached by Moss (1986) and this study regarding whether the alkaline nuclease is required for viral DNA synthesis. One possible explanation for the discrepancy is that in addition to the nuclease lesion in mutant 4-8, an additional leaky ts mutation in one of the other replication genes in this region exists which is responsible for the observed defect in viral DNA synthesis. Although Moss performed marker rescue analysis on the mutation(s) in mutant 4-8, the rescuing fragment was quite large (16-7 kb) and contains the coding regions for several viral genes, including three genes essential for DNA synthesis, UL5, UL8 and UL9 (Carmichael et al., 1988; Carmichael & WeUer, 1989; Matz et al., 1983; Zhu & Weller, 1988) . Further genetic analysis will be required in order to fully explain this discrepancy.
The mutant AN-1 can form plaques efficiently on permissive $22 cells, indicating that complementation by the resident wild-type alkaline nuclease gene (present in approximately five copies per haploid genome) occurs. However, yields of virus AN-1 on $22 cells were decreased approximately 200-fold compared to HSV-1 strain KOS on Vero or $22 cells (Fig. 3) . Thus, although the virus can certainly be propagated on $22 cells, virus growth is somewhat inefficient. One explanation for the inefficient growth may be relatively low levels of alkaline nuclease gene expression in $22 cells compared to HSV-1 strain KOS-infected cells; our inability to detect alkaline nuclease protein or activity in these cells (Fig. 6 and 7 ) supports this hypothesis. Banks et al. (1983) previously reported that alkaline nuclease is an abundant protein in infected cells. Taken together these data raise the interesting possibility that large quantities of alkaline nuclease may be needed for efficient infection. Attempts to correlate complementation of nuc-mutants with expression of the alkaline nuclease gene are currently in progress.
Although substantial information has been collected about its enzymic activities in vitro, intracellular localization and genetic properties, the physiological role of alkaline nuclease during the virus life cycle remains unclear. Based on its nucleolytic abilities, Hoffmann & Cheng (1978) proposed that the viral alkaline nuclease may be involved in the degradation of host cellular DNA to provide deoxynucleotide precursors for viral DNA synthesis. The reutilization of host DNA-derived dTTP for viral DNA synthesis has been reported; however, this is apparently not a major source of precursors for viral DNA (Nutter et aL, 1985) . In addition, the observation that substantial viral DNA synthesis (90% of wild-type levels) occurs in mutant-infected cells (Fig. 4) suggests that DNA precursors do not seem to be limiting, at least in exponentially growing cells in tissue culture. Further studies will be required to determine whether degradation of cellular DNA by alkaline nuclease occurs, and if so, whether this represents a substantial contribution to pools of precursor nucelotides. The presence of an active nuclease in the nucleus of infected cells raises the question of how it is modulated in vivo so that viral DNA is protected from degradation.
Although the alkaline nuclease exhibits endo-and exonucleolytic properties in vitro, especially at high pH, it is possible that its in vivo function might be different (Strobel-Fidler & Francke, 1980) . Suggestions have been made that alkaline nuclease participates directly in viral DNA synthesis either as a helix-destabilizing protein (Hoffmann, 1981) or as a. helicase or topoisomerase (Francke & Garrett, 1982) . However, the observation that the alkaline nuclease does not localize to putative replication compartments (Puvion-Dutilleul & Pichard, 1986; Randall & Dinwoodie, 1986 ) and the demonstration in this study that in the HSV-1 mutant, AN-l, alkaline nuclease is not required for viral DNA synthesis, argue against a direct role for alkaline nuclease in viral DNA synthesis. The fact that alkaline nuclease is not required for origin-containing plasmid amplification in a transient transfection assay designed to identify viral replication genes also argues against a direct role in viral DNA synthesis Wu et al., 1988) .
Another possible role for the alkaline nuclease may arise during recombination. During the HSV life cycle, recombination and replication are closely linked (Amundsen & Parris, 1984; Weber et al., 1988) . Not only is recombination a frequent event between two coinfecting viral genomes (Brown et al., 1973; Honess et al., 1980; Schaffer et al., 1974; Timbury & SubakSharpe, 1973 ), but recombination also occurs within repeated regions of the genome resulting in the inversion of the L and S components relative to one another (Chou & Roizman, 1985; Hayward et al., 1975; Sheldrick & Berthelot, 1975) . By analogy with other viruses with large DNA genomes like the bacteriophage T4, it is possible that some late stages in viral DNA replication actually depend on recombination. For instance, the T4 gene 49 product, endonuclease VII, has been shown to play a role in the resolution of recombination intermediates prior to packaging (Kemper & Brown, 1976; Kemper et al., 1981 ; Kemper & Janz, 1976) . By analogy to T4, the HSV alkaline nuclease may play a role in the resolution of recombination intermediates or in some other step in recombination. If this were its role, a loss of alkaline nuclease activity could lead to inefficient processing or packaging of intermediates.
It has also been proposed that the alkaline nuclease may be required at some stage of maturation or packaging of viral DNA (Hoffmann & Cheng, 1979) . Following synthesis of viral DNA in the form of large concatemers, maturation of viral DNA occurs and involves two steps: the processing of'endless' replicative concatemers to unit-length molecules and the assembly ofcapsids containing a genome-equivalent of HSV DNA (Vlazny et al., 1982) . Several lines of evidence suggest that viral genome maturation involves site-specific cleavage of viral DNA concatemers within the a sequence (Davison & Wilkie, 1981; Mocarski et al., 1985; Mocarski & Roizman, 1982; Spaete & Mocarski, 1985; Stow etal., 1983; Vlazny & Frenkel, 1981 ; Vlazny et al., 1982) . Given the existence of cis-acting signals that are required for cleavage and maturation, it follows that there must be trans-acting factors which recognize these sites and act to carry out cleavage and packaging. One approach to the identification of these functions is the isolation of mutants defective in these processes. Several mutants of HSV-1 representing at least five genes (UL6, UL26, UL28, UL32 and possibly UL54) which make but fail to process viral DNA at the non-permissive temperature have been isolated (Matz et al., 1983; Preston et al., 1983; Rixon et al., 1988; Sherman & Bachenheimer, 1987 . In these experiments, no terminal fragments were observed following restriction enzyme digestion of viral DNA isolated from cells infected at the non-permissive temperature (Preston et al., 1983; Rixon et al., 1988; Sherman & Bachenheimer, 1987 ; this phenotype suggests that cleavage is completely blocked in these mutants at the nonpermissive temperature. Some of these mutations have been mapped to genes encoding known or suspected capsid proteins (Preston et al., 1983; Rixon et al., 1988) , and their existence in HSV-1 and in pseudorabies virus has been taken as evidence that maturation of viral DNA is closely correlated with the formation of full capsids (Ladin et al., 1980; Sherman & Bachenheimer, 1987 . In contrast, AN-1 mutants do not exhibit a complete block of viral DNA processing; DNA from cells infected with virus AN-1 and digested with BamHI exhibits significant amounts of terminal fragments (M. R. Seghatoleslami & S. K. Weller, unpublished results). It seems that cleavage can occur but production of infectious virions is not efficient. Thus, the block appears to be at a later stage than that in the previously isolated packaging mutants. One possible explanation lies in the frequency of appropriate cleavage sites within the large head-to-tail concatemers. Current evidence suggests that L-S junctions exist which contain only one copy of the a sequence and that the a sequence must be duplicated either during, or just prior to, cleavage/packaging Varmuza & Smiley, 1985; J. R. Smiley, personal communication) . It is possible that the alkaline nuclease plays a role in the duplication of the a sequences and, if it is absent, cleavage can only occur at a small subset of junctions which already contain two copies of the a sequence. This could lead to inefficient packaging of viral genomes. The alkaline nuclease has been found in a complex of viral and cellular proteins which bind to the a sequence (Chou & Roizman, 1989) . Further experiments will be required to determine whether the presence of alkaline nuclease in these complexes is fortuitous or reflects its actual involvement in maturation and/or cleavage events.
The results presented in this paper are consistent with either of the latter two proposals for alkaline nuclease function: in the processing of replication or recombination intermediates, or in the duplication or cleavage of the a sequences. Further experimentation will be required to distinguish between these possibilities and to determine whether alkaline nuclease also functions to degrade host DNA to provide precursors for viral DNA synthesis. No evidence to date indicates a sequence specificity for the in vitro nucleolytic activities of the alkaline nuclease. If a role in processing or packaging of intermediates is discovered, the issue of sequence specificity will have to be addressed. Alternatively, the essential role of alkaline nuclease during infection may not be enzymic; it is possible that alkaline nuclease plays a structural role in infection, perhaps during virus assembly. This would be consistent with the apparent requirement for large amounts of the protein for efficient virus production.
